Democratic senator takes Tom Price to task over questionable stock purchases

Patty Murray.
(Image credit: Chip Somodevilla/Getty Images)

Rep. Tom Price (R-Ga.) faced intense questioning from Sen. Patty Murray (D-Wash.) on Wednesday over his decision to purchase Innate Immunotherapeutics stock after a conversation with Rep. Chris Collins (R-N.Y.). "Rep. Price, recent press reports about your investments in the Australian biotech company, Innate Immunotherapeutics, raise some curious questions about your judgments, and I want to review the facts," Murray began. "You made the decision to purchase that stock, not a broker, yes or no?"

"That was a decision I made, yes," Price answered.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Jeva Lange

Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.